As Lurbinectedin is being tested as a second line treatment for patients with relapsed small cell lung cancer after platinum based chemotherapy, can the use of drug releasing nanoparticles be a more focused delivery option for this drug?

More Marcela Nava's questions See All
Similar questions and discussions